Abstract:Differentiated cells retain the genetic information of the donor but the extent to which phenotypic differences between donors or batches of differentiated cells are explained by variation introduced during the differentiation process is not fully understood. In this study, we evaluated four separate batches of commercially available neurons originating from the same iPSCs to investigate whether the differentiation process used in manufacturing iPSCs to neurons affected genome-wide gene expression, modified cy… Show more
“…33 In recent years, studies of chemotherapy neurotoxicity have been performed in commercially available neurons from iPSCs (e.g., iCell Neurons and Peri.4U Neurons). [9][10][11][12][13][14][15][16]19,40 In these cases, cells are typically tested shortly after plating and the outgrowth of neurites is measured using high content imaging. Although neurite outgrowth is a common measurement of the neurodevelopmental effects of chemicals, 41,42 the mature neurite networks investigated in this study more accurately reflect the conditions during exposure to paclitaxel in humans.…”
Section: Figurementioning
confidence: 99%
“…There are several advantages of the current iPSC-SN model to study chemotherapy-induced neurotoxicity compared with similar studies in iCell neurons and Peri.4U neurons. [9][10][11][12][13][14][15][16]19,40 The iPSC-SNs are derived from a well-characterized and widely used iPSC line, 25 with a known genetic background that can be edited for mechanistic investigation of specific genes and for the introduction of human polymorphisms that are associated with chemotherapy-induced peripheral neuropathy. Other iPSC-derived sensory neurons have proven useful for the study of peripheral nerve injury, mechanotransduction, and neurodegeneration.…”
Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting adverse event associated with treatment with paclitaxel and other chemotherapeutic agents. The prevention and treatment of CIPN are limited by a lack of understanding of the molecular mechanisms underlying this toxicity. In the current study, a human induced pluripotent stem cell-derived sensory neuron (iPSC-SN) model was developed for the study of chemotherapy-induced neurotoxicity. The iPSC-SNs express proteins characteristic of nociceptor, mechanoreceptor, and proprioceptor sensory neurons and show Ca 2+ influx in response to capsaicin, α,β-meATP, and glutamate. The iPSC-SNs are relatively resistant to the cytotoxic effects of paclitaxel, with half-maximal inhibitory concentration (IC 50) values of 38.1 µM (95% confidence interval (CI) 22.9-70.9 µM) for 48-hour exposure and 9.3 µM (95% CI 5.7-16.5 µM) for 72-hour treatment. Paclitaxel causes dose-dependent and time-dependent changes in neurite network complexity detected by βIII-tubulin staining and high content imaging. The IC 50 for paclitaxel reduction of neurite area was 1.4 µM (95% CI 0.3-16.9 µM) for 48-hour exposure and 0.6 µM (95% CI 0.09-9.9 µM) for 72-hour exposure. Decreased mitochondrial membrane potential, slower movement of mitochondria down the neurites, and changes in glutamate-induced neuronal excitability were also observed with paclitaxel exposure. The iPSC-SNs were also sensitive to docetaxel, vincristine, and bortezomib. Collectively, these data support the use of iPSC-SNs for detailed mechanistic investigations of genes and pathways implicated in chemotherapy-induced neurotoxicity and the identification of novel therapeutic approaches for its prevention and treatment. Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting toxicity associated with a number of drugs used for the treatment of solid tumors and hematological cancers. 1-3 Drugs with diverse mechanisms of action, including microtubule disruptors, proteasome inhibitors, and DNA-crosslinking agents, all cause significant peripheral neuropathy. CIPN typically presents as burning, tingling, or numbness in the hands and feet that occurs in a glove and stocking distribution. 2,4 In addition to negatively affecting a patient's quality of life, dose reductions, treatment delays, and discontinuation can impact the therapeutic effectiveness of these drugs. 2 Despite years of research, there
“…33 In recent years, studies of chemotherapy neurotoxicity have been performed in commercially available neurons from iPSCs (e.g., iCell Neurons and Peri.4U Neurons). [9][10][11][12][13][14][15][16]19,40 In these cases, cells are typically tested shortly after plating and the outgrowth of neurites is measured using high content imaging. Although neurite outgrowth is a common measurement of the neurodevelopmental effects of chemicals, 41,42 the mature neurite networks investigated in this study more accurately reflect the conditions during exposure to paclitaxel in humans.…”
Section: Figurementioning
confidence: 99%
“…There are several advantages of the current iPSC-SN model to study chemotherapy-induced neurotoxicity compared with similar studies in iCell neurons and Peri.4U neurons. [9][10][11][12][13][14][15][16]19,40 The iPSC-SNs are derived from a well-characterized and widely used iPSC line, 25 with a known genetic background that can be edited for mechanistic investigation of specific genes and for the introduction of human polymorphisms that are associated with chemotherapy-induced peripheral neuropathy. Other iPSC-derived sensory neurons have proven useful for the study of peripheral nerve injury, mechanotransduction, and neurodegeneration.…”
Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting adverse event associated with treatment with paclitaxel and other chemotherapeutic agents. The prevention and treatment of CIPN are limited by a lack of understanding of the molecular mechanisms underlying this toxicity. In the current study, a human induced pluripotent stem cell-derived sensory neuron (iPSC-SN) model was developed for the study of chemotherapy-induced neurotoxicity. The iPSC-SNs express proteins characteristic of nociceptor, mechanoreceptor, and proprioceptor sensory neurons and show Ca 2+ influx in response to capsaicin, α,β-meATP, and glutamate. The iPSC-SNs are relatively resistant to the cytotoxic effects of paclitaxel, with half-maximal inhibitory concentration (IC 50) values of 38.1 µM (95% confidence interval (CI) 22.9-70.9 µM) for 48-hour exposure and 9.3 µM (95% CI 5.7-16.5 µM) for 72-hour treatment. Paclitaxel causes dose-dependent and time-dependent changes in neurite network complexity detected by βIII-tubulin staining and high content imaging. The IC 50 for paclitaxel reduction of neurite area was 1.4 µM (95% CI 0.3-16.9 µM) for 48-hour exposure and 0.6 µM (95% CI 0.09-9.9 µM) for 72-hour exposure. Decreased mitochondrial membrane potential, slower movement of mitochondria down the neurites, and changes in glutamate-induced neuronal excitability were also observed with paclitaxel exposure. The iPSC-SNs were also sensitive to docetaxel, vincristine, and bortezomib. Collectively, these data support the use of iPSC-SNs for detailed mechanistic investigations of genes and pathways implicated in chemotherapy-induced neurotoxicity and the identification of novel therapeutic approaches for its prevention and treatment. Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting toxicity associated with a number of drugs used for the treatment of solid tumors and hematological cancers. 1-3 Drugs with diverse mechanisms of action, including microtubule disruptors, proteasome inhibitors, and DNA-crosslinking agents, all cause significant peripheral neuropathy. CIPN typically presents as burning, tingling, or numbness in the hands and feet that occurs in a glove and stocking distribution. 2,4 In addition to negatively affecting a patient's quality of life, dose reductions, treatment delays, and discontinuation can impact the therapeutic effectiveness of these drugs. 2 Despite years of research, there
“…hiPSCNs offer unique insight into the pathology of human disease by enabling human in vitro models with cells such as cardiomyocytes and neurons that are difficult to ethically obtain by biopsy from human subjects. Batch-to-batch variability in cells produced in academic labs has historically presented significant challenges, but the recent availability of hiPSCNs from commercial vendors with little batch-to-batch variability 6 has broadened access to this technology and improved reproducibility across labs. iCell neurons from Cellular Dynamics are a mixed population of GABAergic and glutamatergic hiPSCNs expressing multiple ligand gated and voltage gated ion channels 7 .…”
Traumatic brain injury (TBI) is a major cause of mortality and morbidity with limited therapeutic options. Traumatic axonal injury (TAI) is an important component of TBI pathology. It is difficult to reproduce TAI in animal models of closed head injury, but in vitro stretch injury models reproduce clinical TAI pathology. Existing in vitro models employ primary rodent neurons or human cancer cell line cells in low throughput formats. This in vitro neuronal stretch injury model employs human induced pluripotent stem cell-derived neurons (hiPSCNs) in a 96 well format. Silicone membranes were attached to 96 well plate tops to create stretchable, culture substrates. A custom-built device was designed and validated to apply repeatable, biofidelic strains and strain rates to these plates. A high content approach was used to measure injury in a hypothesis-free manner. These measurements are shown to provide a sensitive, dose-dependent, multi-modal description of the response to mechanical insult. hiPSCNs transition from healthy to injured phenotype at approximately 35% Lagrangian strain. Continued development of this model may create novel opportunities for drug discovery and exploration of the role of human genotype in TAI pathology.
“…There are several possible explanations for heterogeneity of behavior of hiPSC lines and their derivatives. Key sources of heterogeneity include the genetic background of the hiPSC donors and batch-to-batch variations among cells obtained from the same hiPSC donor during manual steps of multi-month differentiation procedures (Rouhani et al, 2014 ; Morrison et al, 2016 ; Carcamo-Orive et al, 2017 ). Age and sex of cell donors can influence stem cell fate and may be explanatory variables in the behavior of derived cells (Siegel et al, 2013 ).…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.